PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling

Zhiyong Yao1, Bin Sun1, Quan Hong1

  • 1Department of Urology, Air Force General Hospital of People's Liberation Army, Beijing, People's Republic of China.

Abstract

Insights

PACE4 small interfering (si)RNA demonstrated antitumor effects in prostate cancer by inducing apoptosis. This suggests PACE4 may be a therapeutic target, acting via mitochondrial and endoplasmic reticulum stress pathways.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Proprotein convertase PACE4 processes substrates crucial for tumor progression.
  • The role of PACE4 in prostate cancer cell apoptosis remains unelucidated.

Purpose of the Study:

  • To investigate the role of PACE4 in prostate cancer cell apoptosis.
  • To explore the therapeutic potential of targeting PACE4 in prostate cancer.

Main Methods:

  • Human prostate cancer cell lines (DU145, LNCaP, PC3) were transfected with PACE4 small interfering (si)RNA.
  • Apoptosis was assessed using Cell Counting Kit-8 (CCK-8), MTT assay, cell cycle analysis, Hoechst staining, caspase-3/7 activity, and western blot analysis.

Main Results:

  • PACE4 siRNA induced apoptosis and exhibited antitumor activity in prostate cancer cells.
  • PACE4 knockdown increased the Bax/Bcl-2 ratio, leading to cytochrome c release and activating mitochondrial apoptosis.
  • Endoplasmic reticulum stress was induced, evidenced by increased GRP78, GRP94, p-PERK, and p-eIF2α expression.

Conclusions:

  • PACE4 siRNA exerts antitumor effects through mitochondrial and endoplasmic reticulum stress pathways.
  • Targeting PACE4 represents a potential novel therapeutic strategy for prostate cancer.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K